Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 323,499 |
|
|||||
| News | - | ||||||
| Day High | 4.51 | Low High |
|||||
| Day Low | 4.21 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| ADC Therapeutics SA | ADCT | NYSE | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.02 | 0.45% | 4.46 | 18:51:24 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 4.44 | 4.21 | 4.51 | 4.34 | 4.44 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,907 | 323,499 | US$ 4.35 | US$ 1,406,834 | - | 0.359908 - 6.04 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:51:23 | formt | 560 | US$ 4.46 | USD |
ADC Therapeutics SA Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 359M | 82.53M | - | 69.56M | -234.53M | -2.84 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ADC Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ADCT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.76 | 5.08 | 4.21 | 4.74 | 358,954 | -0.30 | -6.30% |
| 1 Month | 4.60 | 5.38 | 4.11 | 4.73 | 483,623 | -0.14 | -3.04% |
| 3 Months | 3.61 | 6.04 | 3.23 | 4.54 | 643,750 | 0.85 | 23.55% |
| 6 Months | 0.651 | 6.04 | 0.359908 | 2.94 | 708,603 | 3.81 | 585.10% |
| 1 Year | 1.92 | 6.04 | 0.359908 | 2.47 | 552,512 | 2.54 | 132.29% |
| 3 Years | 24.44 | 32.00 | 0.359908 | 6.59 | 424,083 | -19.98 | -81.75% |
| 5 Years | 30.00 | 56.5899 | 0.359908 | 10.81 | 383,753 | -25.54 | -85.13% |
ADC Therapeutics Description
| ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212. |
